State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, Shanghai, China.
Department of Gastroenterology and Guangzhou Key Laboratory of Digestive Disease, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Cancer Discov. 2016 Jul;6(7):784-801. doi: 10.1158/2159-8290.CD-15-0921. Epub 2016 May 4.
Long noncoding RNAs (lncRNA) play a role in carcinogenesis. However, the function of lncRNAs in human gastric cancer remains largely unknown. In this study, we identified a novel lncRNA, GClnc1, which was upregulated and associated with tumorigenesis, tumor size, metastasis, and poor prognosis in gastric cancer. GClnc1 affected gastric cancer cell proliferation, invasiveness, and metastasis in multiple gastric cancer models. Mechanistically, GClnc1 bound WDR5 (a key component of histone methyltransferase complex) and KAT2A histone acetyltransferase, acted as a modular scaffold of WDR5 and KAT2A complexes, coordinated their localization, specified the histone modification pattern on the target genes, including SOD2, and consequently altered gastric cancer cell biology. Thus, GClnc1 is mechanistically, functionally, and clinically oncogenic in gastric cancer. Targeting GClnc1 and its pathway may be meaningful for treating patients with gastric cancer.
This report documents a novel lncRNA, GClnc1, which may act as a scaffold to recruit the WDR5 and KAT2A complex and modify the transcription of target genes. This study reveals that GClnc1 is an oncogenic lncRNA in human gastric cancer. Cancer Discov; 6(7); 784-801. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 681.
长非编码 RNA(lncRNA)在致癌作用中发挥作用。然而,lncRNAs 在人类胃癌中的功能在很大程度上仍然未知。在这项研究中,我们鉴定了一种新型的 lncRNA,GClnc1,其上调与胃癌的发生、肿瘤大小、转移和不良预后相关。GClnc1 在多种胃癌模型中影响胃癌细胞的增殖、侵袭和转移。机制上,GClnc1 结合 WDR5(组蛋白甲基转移酶复合物的关键组成部分)和 KAT2A 组蛋白乙酰转移酶,作为 WDR5 和 KAT2A 复合物的模块化支架,协调它们在靶基因上的定位,指定组蛋白修饰模式,包括 SOD2,并因此改变胃癌细胞的生物学特性。因此,GClnc1 在胃癌中具有机制上、功能上和临床上的致癌性。针对 GClnc1 及其通路可能对治疗胃癌患者具有重要意义。
本报告记录了一种新型 lncRNA,GClnc1,它可能作为一种支架来招募 WDR5 和 KAT2A 复合物,并修饰靶基因的转录。本研究揭示了 GClnc1 是人类胃癌中的一种致癌 lncRNA。癌症发现;6(7);784-801。2016 年 AACR。本文在本期特色文章中重点介绍,第 681 页。